| Autor: |
Boatman, P. D., Ogbu, C. O., Eguchi, M., Kim, H.-O., Nakanishi, H., Cao, B., Shea, J. P., Kahn, M. |
| Zdroj: |
Journal of Medicinal Chemistry; April 1999, Vol. 42 Issue: 8 p1367-1375, 9p |
| Abstrakt: |
Constrained dipeptide mimetic templates were designed to mimic the secondary structure of peptides in a β-strand conformation. Two templates corresponding to the d-Phe-Pro portion of the thrombin inhibitor d-Phe-Pro-ArgCH2Cl were synthesized and converted into nine α-ketoamide and α-ketoheterocycle inhibitors of thrombin. Additionally, a template corresponding to l-Phe-Pro was synthesized and converted to a thrombin inhibitor. The in vitro inhibition of thrombin by these compounds was determined, and those corresponding to the d-Phe-Pro were found to be more potent inhibitors than the l-Phe-Pro mimetic. The α-ketoamides were found to be more potent than the α-ketoheterocycles but had much slower on rates. By comparison of a series of α-ketoamide analogues, it is apparent that the there is a preference for binding of bulky hydrophobic substituents in the P portion of the thrombin active site. Three of the inhibitors (MOL098, MOL144, and MOL174) were screened against a series of coagulation and anticoagulation enzymes and found to be selective for inhibition of the coagulation enzymes. Two of the inhibitors were tested in in vitro models of intestinal absorption and found to have low absorption potential. The compounds were then tested in vivo in both rats and primates, and one of them (MOL144) was approximately 25% absorbed in both species. This study has delineated the synthesis of constrained dipeptide β-strand mimetics and validated the potential for compounds of this type as potent thrombin inhibitors and possible drug leads. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
